cart 0

ISCTR Donation

$ Donation Amount:

Personal Info

First Name *

Last Name

Email Address *

Credit Card Info

This is a secure SSL encrypted payment.

Card Number *

CVC *

Cardholder Name *

Expiration *

Billing Details

Country *

Address 1 *

Address 2

City *

State *

Zip / Postal Code *

Terms

Acceptance of any contribution, gift or grant is at the discretion of the ISCTR. The International Society for Cardiovascular Translational Research will not accept any gift unless it can be used or expended consistently with the purpose and mission of the ISCTR | International Society for Cardiovascular Translational Research.

No irrevocable gift, whether outright or life-income in character, will be accepted if under any reasonable set of circumstances the gift would jeopardize the donor’s financial security.

International Society for Cardiovascular Translational Research will refrain from providing advice about the tax or other treatment of gifts and will encourage donors to seek guidance from their own professional advisers to assist them in the process of making their donation.

The ISCTR | International Society for Cardiovascular Translational Research will accept donations of cash or publicly traded securities. Gifts of in-kind services will be accepted at the discretion of the ISCTR | International Society for Cardiovascular Translational Research.

Certain other gifts, real property, personal property, in-kind gifts, non-liquid securities, and contributions whose sources are not transparent or whose use is restricted in some manner, must be reviewed prior to acceptance due to the special obligations raised or liabilities they may pose for ISCTR | International Society for Cardiovascular Translational Research.

The ISCTR | International Society for Cardiovascular Translational Research will provide acknowledgments to donors meeting tax requirements for property received by the charity as a gift. However, except for gifts of cash and publicly traded securities, no value shall be ascribed to any receipt or other form of substantiation of a gift received by ISCTR | International Society for Cardiovascular Translational Research.

The ISCTR | International Society for Cardiovascular Translational Research will respect the intent of the donor relating to gifts for restricted purposes and those relating to the desire to remain anonymous. With respect to anonymous gifts, the ISCTR | International Society for Cardiovascular Translational Research will restrict information about the donor to only those staff members with a need to know.

The ISCTR | International Society for Cardiovascular Translational Research will not compensate, whether through commissions, finders' fees, or other means, any third party for directing a gift or a donor to the ISCTR | International Society for Cardiovascular Translational Research.

Show Terms

Agree to Terms?

Donation Total: $100.00

2016-2019

Annual Summits

Overview

The ISCTR Summits gather experts from around the globe to present in-depth, up-to-the-minute information about cardiovascular translational research. With online access, these summits provide comprehensive presentations that can be reviewed on your schedule and offer keynote addresses from the recipients of the ISCTR-Nelson Award for Innovation and Translation in Cardiovascular Medicine including world-renowned physicians such as Eugene Braunwald, Magdi Yacoub, Spencer King, Alain Cribier, and former FDA Commissioner Robert Califf.

Target Audience

The summits focus on topics in cardiovascular translational research, discussed both in terms of their place in the pathways of translational research as well as points of view from clinical scientists, payors, guideline writers, patients, reimbursement officials, and others. Professionals who would benefit from these summits include:

Clinician
Engineers
Industry
Inventors
Medical Students
Reimbursement Agencies
Regulators
Payers
Investors

Summit Benefits

Most up-to-date information on translational innovation
Singularly focused on research and medical device product development
Presentations from international experts and key opinion leaders

Keynote Speaker

Spencer King, III, MD

Professor Emeritus, Emory University School of Medicine

2019

Translational Pathways for Cardiovascular Devices

September 25, 2019

Discussions centered on development of diagnostic and therapeutic devices, including those for complex coronary lesions, heart failure, imaging, and more

Purchase 2019

2018

Cardiovascular Translational Research

September 21, 2018

Insights into translational pathways for development and iteration of specific types of devices, including valves, stents, and ablative and assist devices